Abstract

Medical Errors: Pre-Analytical Issue in Patient SafetyThe last few decades have seen a significant decrease in the rates of analytical errors in clinical laboratories, while a growing body of evidence demonstrates that the pre- and post-analytical steps of the total testing process (TTP) are more error-prone than the analytical phase. In particular, most errors are identified in pre-pre-analytic steps outside the walls of the laboratory, and beyond its control. However, in a patient-centred approach to the delivery of health care services, there is the need to investigate, in the total testing process, any possible defect that may have a negative impact on the patient, irrespective of which step is involved and whether the error depends on a laboratory professional (e.g. calibration or testing error) or a non-laboratory operator (e.g. inappropriate test request, error in patient identification and/or blood collection). In the pre-analytic phase, the frequency of patient/specimens misidentification and the presence of possible causes of specimen rejection (haemolysis, clotting, insufficient volume, etc.) represent a valuable risk for patient safety. Preventing errors in the pre-analytical steps requires both technological developments (wristband, barcodes, pre-analytical workstations) and closer relationships with the clinical world to achieve an effective team-working cooperation. The most important lesson we have learned, therefore, is that laboratory errors and injuries to patients can be prevented by redesigning systems that render it difficult for all caregivers and in all steps of the total testing process to make mistakes.

Highlights

  • Medical error and patient harm have been described and studied for well over a century

  • Summary: The last few decades have seen a significant decrease in the rates of analytical errors in clinical laboratories, while a growing body of evidence demonstrates that the pre- and post-analytical steps of the total testing process (TTP) are more error-prone than the analytical phase

  • In a patient-centred approach to the delivery of health care services, there is the need to investigate, in the total testing process, any possible defect that may have a negative impact on the patient, irrespective of which step is involved and whether the error depends on a laboratory professional or a non-laboratory operator

Read more

Summary

Introduction

Medical error and patient harm have been described and studied for well over a century. Identification errors were noted for three patients and 14 related tests (875 ppm) in the latter study, but were significantly fewer than those observed in the former study for specimens collected from the infusion route Other studies confirmed these data, underlining the need to improve the analytical quality, which remains the »core« of laboratory activity, but the pre-, and post-analytical steps [7,8,9,10,11]. The Working Group on »Laboratory Errors and Patient Safety« (WG-LEPS) of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has undertaken a project named »Model of quality indicators« based on the identification of valuable and consensually accepted quality indicators in all steps of the testing process. Participant laboratories may introduce the data collected in their own institution on each and all quality indicators in a developed website (www3.centroricercabiomedica.it) [35]

Conclusions
Findings
36. ISO 15189
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call